vs
Side-by-side financial comparison of Commercial Vehicle Group, Inc. (CVGI) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $154.8M, roughly 1.9× Commercial Vehicle Group, Inc.). On growth, Commercial Vehicle Group, Inc. posted the faster year-over-year revenue change (-5.2% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -10.8%).
WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
CVGI vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $154.8M | $295.9M |
| Net Profit | — | $38.0M |
| Gross Margin | 9.7% | 64.6% |
| Operating Margin | -1.2% | 18.4% |
| Net Margin | — | 12.8% |
| Revenue YoY | -5.2% | -6.4% |
| Net Profit YoY | — | 68.3% |
| EPS (diluted) | — | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $154.8M | $295.9M | ||
| Q3 25 | $152.5M | — | ||
| Q2 25 | $172.0M | $317.0M | ||
| Q1 25 | $169.8M | $316.2M | ||
| Q4 24 | $163.3M | $297.0M | ||
| Q3 24 | $171.8M | $289.5M | ||
| Q2 24 | $193.7M | $306.1M | ||
| Q1 24 | $194.6M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $-7.1M | — | ||
| Q2 25 | $-4.8M | $-17.7M | ||
| Q1 25 | $-4.3M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $9.5M | $33.6M | ||
| Q2 24 | $-1.6M | $40.6M | ||
| Q1 24 | $2.9M | $49.1M |
| Q4 25 | 9.7% | 64.6% | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 11.4% | 62.7% | ||
| Q1 25 | 10.5% | 67.9% | ||
| Q4 24 | 8.0% | 65.3% | ||
| Q3 24 | 9.6% | 63.2% | ||
| Q2 24 | 10.6% | 66.4% | ||
| Q1 24 | 11.9% | 67.4% |
| Q4 25 | -1.2% | 18.4% | ||
| Q3 25 | -0.7% | — | ||
| Q2 25 | 0.5% | -7.5% | ||
| Q1 25 | 0.8% | 12.2% | ||
| Q4 24 | -3.2% | 16.0% | ||
| Q3 24 | -0.6% | 13.8% | ||
| Q2 24 | 0.5% | 15.0% | ||
| Q1 24 | 2.3% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | -4.6% | — | ||
| Q2 25 | -2.8% | -5.6% | ||
| Q1 25 | -2.5% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | 5.5% | 11.6% | ||
| Q2 24 | -0.8% | 13.3% | ||
| Q1 24 | 1.5% | 16.2% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-0.11 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | $-0.05 | $0.26 | ||
| Q1 24 | $0.09 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $172.9M |
| Total DebtLower is stronger | $104.9M | $260.0M |
| Stockholders' EquityBook value | $133.4M | $2.0B |
| Total Assets | $391.7M | $2.5B |
| Debt / EquityLower = less leverage | 0.79× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | — | $187.5M | ||
| Q2 24 | — | $152.9M | ||
| Q1 24 | — | $145.3M |
| Q4 25 | $104.9M | $260.0M | ||
| Q3 25 | $108.2M | — | ||
| Q2 25 | $118.2M | $346.0M | ||
| Q1 25 | $117.4M | $330.0M | ||
| Q4 24 | $135.5M | $300.0M | ||
| Q3 24 | $128.8M | $300.0M | ||
| Q2 24 | $142.0M | $319.0M | ||
| Q1 24 | $155.7M | $389.0M |
| Q4 25 | $133.4M | $2.0B | ||
| Q3 25 | $136.5M | — | ||
| Q2 25 | $142.6M | $1.9B | ||
| Q1 25 | $136.7M | $2.0B | ||
| Q4 24 | $135.6M | $2.1B | ||
| Q3 24 | $179.3M | $2.1B | ||
| Q2 24 | $169.6M | $2.1B | ||
| Q1 24 | $175.5M | $2.0B |
| Q4 25 | $391.7M | $2.5B | ||
| Q3 25 | $400.3M | — | ||
| Q2 25 | $429.8M | $2.6B | ||
| Q1 25 | $419.8M | $2.6B | ||
| Q4 24 | $424.6M | $2.7B | ||
| Q3 24 | $495.3M | $2.7B | ||
| Q2 24 | $503.2M | $2.7B | ||
| Q1 24 | $509.2M | $2.7B |
| Q4 25 | 0.79× | 0.13× | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 0.83× | 0.18× | ||
| Q1 25 | 0.86× | 0.16× | ||
| Q4 24 | 1.00× | 0.14× | ||
| Q3 24 | 0.72× | 0.14× | ||
| Q2 24 | 0.84× | 0.15× | ||
| Q1 24 | 0.89× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | — |
| Free Cash FlowOCF − Capex | $8.7M | — |
| FCF MarginFCF / Revenue | 5.6% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | — | ||
| Q3 25 | $-1.7M | — | ||
| Q2 25 | $18.9M | $98.2M | ||
| Q1 25 | $15.2M | $41.1M | ||
| Q4 24 | $-26.6M | $84.3M | ||
| Q3 24 | $-17.1M | $63.9M | ||
| Q2 24 | $12.6M | $75.5M | ||
| Q1 24 | $-2.4M | $81.0M |
| Q4 25 | $8.7M | — | ||
| Q3 25 | $-3.5M | — | ||
| Q2 25 | $17.4M | $93.3M | ||
| Q1 25 | $11.4M | $31.0M | ||
| Q4 24 | $-30.6M | $77.5M | ||
| Q3 24 | $-20.3M | $54.7M | ||
| Q2 24 | $6.4M | $57.5M | ||
| Q1 24 | $-7.4M | $64.5M |
| Q4 25 | 5.6% | — | ||
| Q3 25 | -2.3% | — | ||
| Q2 25 | 10.1% | 29.4% | ||
| Q1 25 | 6.7% | 9.8% | ||
| Q4 24 | -18.7% | 26.1% | ||
| Q3 24 | -11.8% | 18.9% | ||
| Q2 24 | 3.3% | 18.8% | ||
| Q1 24 | -3.8% | 21.3% |
| Q4 25 | 2.3% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.9% | 1.5% | ||
| Q1 25 | 2.2% | 3.2% | ||
| Q4 24 | 2.4% | 2.3% | ||
| Q3 24 | 1.9% | 3.2% | ||
| Q2 24 | 3.2% | 5.9% | ||
| Q1 24 | 2.6% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | -1.79× | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | -0.80× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVGI
| Global Seating | $70.7M | 46% |
| Global Electrical Systems | $49.7M | 32% |
| Trim Systems And Components | $34.4M | 22% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
